Continuous, hyperfractionated, accelerated radiotherapy (CHART).

por Dische, S., Saunders, M. I.
Publicado 1989

Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?

por Eakin, R. L., Saunders, M. I.
Publicado 2000

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer:...

por Ataman, Ö U, Bentzen, S M, Saunders, M I, Dische, S
Publicado 2001

Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses.

por Dische, S., Saunders, M. I., Lee, M. E., Adams, G. E., Flockhart, I. R.
Publicado 1977

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.

por Saunders, M. I., Dische, S., Barrett, A., Parmar, M. K., Harvey, A., Gibson, D.
Publicado 1996

The radiosensitizer Ro 03-8799 and the concentrations which may be achieved in human tumours: a preliminary study.

por Saunders, M. I., Dische, S., Fermont, D., Bishop, A., Lenox-Smith, I., Allen, J. G., Malcolm, S. L.
Publicado 1982

A drug for improved radiosensitization in radiotherapy.

por Dische, S., Fowler, J. F., Saunders, M. I., Stratford, M. R., Anderson, P., Minchinton, A. I., Lee, M. E.
Publicado 1980

The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.

por Dische, S., Saunders, M. I., Riley, P. J., Hauck, J., Bennett, M. H., Stratford, M. R., Minchinton, A. I.
Publicado 1981

p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy.

por Wilson, G. D., Richman, P. I., Dische, S., Saunders, M. I., Robinson, B., Daley, F. M., Ross, D. A.
Publicado 1995

Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

por Hoskin, P. J., Saunders, M. I., Phillips, H., Cladd, H., Powell, M. E., Goodchild, K., Stratford, M. R., Rojas, A.
Publicado 1997

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.

por Wilson, G. D., McNally, N. J., Dische, S., Saunders, M. I., Des Rochers, C., Lewis, A. A., Bennett, M. H.
Publicado 1988

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer.

por Saunders, M. I., Rojas, A., Lyn, B. E., Pigott, K., Powell, M., Goodchild, K., Hoskin, P. J., Phillips, H., Verma, N.
Publicado 1998

Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.

por Bennett, M. H., Wilson, G. D., Dische, S., Saunders, M. I., Martindale, C. A., Robinson, B. M., O'Halloran, A. E., Leslie, M. D., Laing, J. H.
Publicado 1992

To restore coastal marine areas, we need to work across multiple habitats simultaneously

por Vozzo, M. L., Doropoulos, C., Silliman, B. R., Steven, A., Reeves, S. E., ter Hofstede, R., van Koningsveld, M., van de Koppel, J., McPherson, T., Ronan, M., Saunders, M. I.
Publicado 2023

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans

por Alonzi, R, Padhani, A R, Maxwell, R J, Taylor, N J, Stirling, J J, Wilson, J I, d′Arcy, J A, Collins, D J, Saunders, M I, Hoskin, P J
Publicado 2009